Within a certain price range free samples are available
customized
Product Description
Maviret is a fixed-dose combination of two pan genotypic , direct-acting antiviral agents, glecaprevir (NS3/4A protease inhibitor) and pibrentasvir (NS5A inhibitor), targeting multiple steps in the HCV viral lifecycle.